L 59 TGF-β LAP degradation products serve as a promising blood biomarker for liver fibrogenesis in mice
Conclusions:
L
59
LAP-DPs reflect PLK-dependent TGF-β activation and the increase in αSMA-positive activated HSCs in liver injury, thereby serving as a novel blood biomarker for liver fibrogenesis.
Source: Fibrogenesis and Tissue Repair - Category: Biomedical Science Authors: Mitsuko HaraIkuyo InoueYuta YamazakiAkiko KiritaTomokazu MatsuuraScott FriedmanDaniel RifkinSoichi Kojima Source Type: research
More News: Bile | Biomedical Science | Cirrhosis | Gastroschisis Repair | Liver | Urology & Nephrology